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A Few Pieces of the Puzzle*Leyla Elif Sade, MDSEE PAGE 411E ndothelium plays a critical role in maintaininghealthy homeostatic properties of the vascu-lature. Endothelial dysfunction promotes
atherosclerosis by creating a vasospastic, prothrom-
botic, and proinflammatory milieu. Therefore, the
assessment of endothelial function as a surrogate
marker of arterial health has gained significant inter-
est for clinical risk assessment beyond the risk
conveyed by a structural impediment to flow (1).
Furthermore, the observation that cardiovascular
events may occur remotely from the site in which
the endothelial dysfunction is detected prompted
clinical studies in search for peripheral vascular
endothelial dysfunction as a predictor of cardiovascu-
lar events.
Endothelial dysfunction is characterized by a par-
adoxical vasoconstriction or attenuated dilation due
to reduced endothelium-dependent nitric oxide (NO)
release. In earlier studies, the response of the
epicardial arteries to infused acetylcholine was
measured invasively to assess endothelial function in
the coronary circulation. Later on, a number of
noninvasive methods has been introduced for this
purpose including forearm flow-mediated dilation
(FMD) of the brachial artery and, more recently, pulse
amplitude tonometry (PAT), which measures flow-
mediated volumetric changes in the fingertip.
Despite the association of FMD with traditional
atherosclerotic risk factors and cardiovascular risk
(1,2), its integration into clinical practice has been
limited due to a number of technical difficulties.*Editorials published in JACC: Cardiovascular Imaging reflect the views
of the authors and do not necessarily represent the views of JACC:
Cardiovascular Imaging or the American College of Cardiology.
From the Department of Cardiology, University of Baskent, Ankara,
Turkey. Dr. Sade has reported that she has no relationships relevant to
the contents of this paper to disclose.Digital pulse amplitude tonometry (PAT) is a prom-
ising technique that quantifies pulse amplitude and
measures volumetric changes in response to reactive
hyperemia in the fingertip. Simultaneous measure-
ments of the signals from the contralateral arm not
experiencing hyperemia serve as control for systemic
vascular tone. Thereby, a reactive hyperemia index
(RHI) in relation to the control arm is obtained.
Nohria et al. (3) have shown that approximately 60%
of the PAT-RHI response is mediated by NO release.
Subsequently, PAT was shown to correlate with cor-
onary endothelial function (4), showed decrement
with obstructive and nonobstructive coronary artery
disease (CAD) (5) and cardiovascular risk factors (6),
although no correlation was found between FMD and
PAT (7), one being a marker of macrovascular and the
other a microvascular endothelial function. In addi-
tion, PAT and FMD had differing patterns in risk
factor associations (7).In this issue of iJACC, Michelsen et al. (8) examined
whether peripheral vascular function assessed by
PAT-RHI is associated with coronary microvascular
function measured by coronary flow velocity reserve
(CFVR) in women with angina-like chest pain and no
obstructive CAD in a medium sized population
randomly selected after systematic screening of all
women referred to coronary angiography. The study
population is relevant for several reasons: angina is
more prevalent in women despite lower rates of acute
coronary syndromes yet higher rates of hospitaliza-
tions for angina and death after myocardial infarction
(9–11). Microvascular dysfunction and nonobstructive
CAD are highly prevalent in women with chest pain
(9). Furthermore, women with persistent angina,
despite nonobstructive CAD have higher risk of car-
diac events if there is evidence of microvascular
dysfunction (12,13). Accordingly, reliance upon
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 9 , N O . 4 , 2 0 1 6 Sade
A P R I L 2 0 1 6 : 4 1 8 – 2 0 Editorial Comment
419identifying patients at risk by means of alternative
strategies rather than detecting obstructive lesions is
important to minimize diagnostic imprecision and
therapeutic indecision in women. Noninvasive stress
tests remain insensitive for the diagnosis of non-
obstructive or microvascular CAD in women. Perfu-
sion imaging with positron emission tomography or
cardiac magnetic resonance are of value but have
limited access and high cost. Vascular wall imaging
by intravascular ultrasonography or coronary com-
puterized tomography angiography are also viable
options that provide information about the structure
and composition of atherosclerotic plaques. However,
thinking simply, a clinically applicable test for vas-
cular function would be of great value if it helps
to improve early diagnosis, risk stratification and
therapeutic interventions in symptomatic women
over and above the detection of coronary obstructive
lesions. Assessment of CFVR is an already well-
established tool for evaluation of both epicardial
and microvascular CAD. Its relation to conventional
risk factors and its predictive value for CAD
have been tested in various patient populations
including women with normal appearing coronary
angiograms (14).
The findings presented by Michelsen et al. (8) are
clinically important. They show that PAT-RHI and
CFVR, 2 relevant noninvasive vascular function
parameters, are not interchangeable, do not correlate
with each other, differ significantly in their relation to
traditional risk factors, and clearly provide different
information about distinct aspects of vascular
biology. Of note, Matsuzawa et al. (5) previously
assessed coronary endothelial function by using
acetylcholine and CFVR by adenosine provocation
tests invasively in women with chest pain undergoing
coronary angiography. In that study, RHI-PAT was
significantly associated with coronary endothelial
function and predicted nonobstructive CAD, however
their finding of no correlation between RHI-PAT and
CFVR assessed by adenosine provocation cannot
completely negate the potential relationship between
RHI-PAT and non–endothelium-dependent coronary
microvascular disease as adenosine test results were
comparable between nonobstructive CAD and no
ischemic disease groups in their study. This leaves a
gap of knowledge about the association between RHI-
PAT and endothelial independent coronary micro-
vascular function which is presently addressed by
Michelsen et al. (8). Several reasons may help to un-
derstand the differing aspects of these 2 functional
tests: CFVR is regarded as a measure of mainly
endothelium independent function of the coronarymicrovasculature. CFVR as assessed by dipyridamole
is mediated by the inhibition of adenosine reuptake
and catabolism, thereby reflects the smooth muscle
cell relaxation in the coronaries. In contrast, PAT-RHI
is a measure of inadequate microvascular vaso-
dilator capacity in response to reactive hyperemia
mainly mediated by endothelial NO bioactivity. In
addition, PAT hyperemic responses at the digital
microvessel level should be considered in the
context of anatomically complex fingertip vascula-
ture, consisting of a dual circulation with arteriove-
nous anastomoses and distinct physiology. Also,
both pathological and nonpathological conditions,
including temperature in the environment, auto-
nomic nervous system tone, blood pressure, valvular
calcifications, immune activation, and many others
can potentially interfere with PAT-RHI and CFVR
measurements, respectively. Finally, atherosclerosis
may have different manifestations in vascular bed
depending on stages of disease process, risk factor
profile, and site specific predilection for vascular
involvement. This study underlines the importance
of assessing vascular functions in more than one
vascular bed and the need to define which testing
modalities give the best clinical and prognostic
information in different patient populations. Of note,
the regulation of vascular tone is only one aspect of
the complex endothelial function.
Although PAT has several technical advantages as a
simple, automated, repeatable test, there is still much
work to be done before it can be integrated into
clinical practice. Standardization among laboratories,
population normal data, additive risk predictive
value (particularly in intermediate-risk subjects),
alteration of the measurements with therapeutic
interventions, and the relation of this alteration to
change in the risk need further exploration and
evidence. Meanwhile, recent data demonstrated
that PAT-RHI is an independent and additive risk
marker to Framingham risk score for adverse cardiac
events (6,15).
In conclusion; the assessment of vascular function
seems to be valuable to capture pathobiological
effects of unmeasured risk factors and deserves
further investigation. Elucidating the inferences from
different vascular function tests for diagnosis, car-
diovascular risk prediction and gauging response to
therapy is an attractive goal awaiting further studies.
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